WAL 2014 FU (Talsaclidine) : A preferentially neuron activating muscarinic agonist for the treatment of Alzheimer's disease: Challenges and opportunities for developing muscarinic receptor subtype-based therapeutic agents

Saved in:
Bibliographic Details
Published in:Drug development research 1997, Vol.40 (2), p.144-157
Main Authors: ENSINGER, H. A, BECHTEL, W.-D, BIRKE, F. W, MENDLA, K. D, MIERAU, J, SPECK, G, TRÖGER, W
Format: Article
Language:English
Subjects:
Biological and medical sciences
Medical sciences
Neuropharmacology
Neuroprotective agent
Pharmacology. Drug treatments
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0272-4391
1098-2299